OR (95% CI) post-intervention compared to baseline | ||||
---|---|---|---|---|
Total post-intervention sample in 15 practices (n = 40,256) | Cardiovascular risk assessment level post-intervention | |||
Low/moderate (n = 17,365) | High (n = 2334) | Established CVD (n = 4975) | ||
Risk factor assessment | ||||
Blood pressurea | 1.23 (0.90-1.70) | 1.36 (0.82-2.25) | 1.12 (0.85-1.48) | 1.22 (0.80-1.86) |
Blood lipidsb | 1.22 (0.94-1.58) | 1.21 (0.75-1.95) | 1.40 (0.56-3.49) | 1.29 (0.93-1.79) |
BMIb | 1.19 (0.99-1.42) | 1.19 (0.95-1.50) | 1.40 (0.90-2.19) | 1.17 (0.93-1.46) |
Waistb circumferenceb | 1.32 (0.74-2.35) | 1.27 (0.61-2.65) | 1.41 (0.81-2.45) | 1.34 (0.88-2.03) |
Smoking statusb | 1.17 (0.91-1.48) | 1.13 (0.91-1.38) | 1.09 (0.75-1.38) | 1.11 (0.88-1.38) |
CVD risk factors | ||||
Overweight/obesity | 0.97 (0.94-1.00) | 0.96 (0.91-1.01) | 0.80 (0.63-1.02) | 1.00 (−.90-1.11) |
Waist circumferencec | 1.02 (0.68- 1.53) | 0.99 (0.62-1.60) | 0.86 (0.61-1.22) | 1.07 (0.73-1.55) |
Current smoker | 0.99 (0.94- 1.05) | 0.91 (0.81-1.02) | 1.05 (0.98-1.13) | 1.05 (0.92-1.20) |
CVD targets achieved | ||||
Blood pressure | 1.02 (0.90-1.16) | 1.08 (0.97-1.21) | 0.99 (0.70-1.40) | 1.16 (1.02-1.33) |
Total cholesterol | 0.99 (0.92-1.06) | 0.99 (0.91-1.08) | 1.15 (0.90-1.46) | 0.95 (0.84-1.07) |
LDL cholesterol | 0.98 (0.92-1.04) | 1.00 (0.94-1.06) | 1.00 (0.83-1.20) | 0.98 (0.87-1.11) |
HDL cholesterol | 1.08 (0.99-1.18) | 1.09 (1.00-1.20) | 0.99 (0.84-1.13) | 1.08 (0.95-1.23) |
Prescribed CVD risk-reducing medications | ||||
Prescribed risk-reducing medication(s)d | – | – | 1.07 (0.97-1.19) | 0.96 (0.91-1.02) |